Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer.
Degeling, Koen; Schivo, Stefano; Mehra, Niven; Koffijberg, Hendrik; Langerak, Rom; de Bono, Johann S; IJzerman, Maarten J.
; 20(10): 1411-1419, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29241901
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.
Integrative clinical genomics of advanced prostate cancer.
Blood-based gene expression profiling in castrate-resistant prostate cancer.
Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy.
Aggressive variants of castration-resistant prostate cancer.
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients.
Targeting molecular resistance in castration-resistant prostate cancer.
Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer.